FLGT · Company research
Fulgent Genetics, Inc. Common Stock (FLGT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 20.57 | $658,166,600 | 631861600.00 | 4.6954643628509719 | — | — | 7.7078616683647777 | 0.66081912797971055818 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.